Literature DB >> 9461244

Salidiuretic action by genistein in the isolated, perfused rat kidney.

I Giménez1, R M Martinez, M Lou, J A Mayoral, R P Garay, J O Alda.   

Abstract

The urinary isoflavonoid genistein inhibits membrane Na-K-Cl cotransporters at similar concentrations as furosemide, but the significance of this action is unknown. Genistein was therefore investigated in rats for its potential salidiuretic actions. In the isolated, perfused rat kidney, genistein induced a maximal salidiuretic action similar to that of furosemide but was 3 to 5 times less potent than furosemide in terms of active doses (natriuresis EC50, 237+/-92 versus 56+/-20 micromol/L for genistein and furosemide, respectively). Genistein and furosemide had no additive salidiuretic actions. Genistein had no significant effect on glomerular filtration rate but was able to significantly reduce renal vascular resistance with respect to vehicle isolated perfused kidney. Indomethacin (10 micromol/L), a blocker of prostaglandin biosynthesis, reduced salidiuresis and renal vasorelaxation by genistein. Subcutaneous genistein (15 mg/kg) induced a statistically significant increase in diuresis and natriuresis with respect to vehicle during the first 6 hours of administration in rats. In conclusion, genistein compares well with furosemide in vitro for its salidiuretic profile and potency in the isolated perfused rat kidney and is also natriuretic by the subcutaneous route in the rat. Further studies are required to investigate potential natriuretic and perhaps hypotensive actions of dietary genistein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461244     DOI: 10.1161/01.hyp.31.2.706

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  2 in total

Review 1.  Diet and Diabetic Kidney Disease: Plant Versus Animal Protein.

Authors:  Ranjani N Moorthi; Colby J Vorland; Kathleen M Hill Gallant
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

2.  Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.

Authors:  Pian Xiong; Yong-Fen Zhu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.